OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an important source of recurrent cardiovascular events. The presence of high-risk plaques (HRP), identified by optical coherence tomography (OCT) in lesions with negative FFR, has been associated with worse long-term clinical outcomes.

The aim of this prospective, observational, multicenter study was to evaluate the association between HRP and cardiovascular events after MI during a 5-year follow-up period.

A total of 438 patients with recent MI (STEMI or NSTEMI) were included. OCT was performed in all intermediate non-culprit lesions (30–90% visual stenosis) with an FFR >0.80. HRP was defined according to OCT criteria as the presence of at least two of the following three features: lipid arc ≥90°, minimum fibrous cap thickness <65 µm, and plaque rupture or thrombus.

The primary endpoint (PEP) was patient-level major adverse cardiovascular events (MACE), defined as cardiac death, non-fatal MI, or unplanned revascularization at 5 years.

The prevalence of HRP was 34% (143 out of 420 analyzed patients). Regarding outcomes, the MACE rate was significantly higher in the HRP group compared with patients without HRP (18.9% vs. 10.8%; HR 1.87; 95% CI: 1.11–3.14; p=0.017).

When analyzing the individual components of the primary endpoint, the risk of non-fatal MI was four times higher in patients with HRP (HR 4.07; p=0.013), while the need for unplanned revascularization was nearly doubled (HR 1.97; p=0.027).

Read also: Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

The risk associated with HRP was mainly concentrated within the first two years of follow-up (HR 2.67; p=0.006). Between years 2 and 5, the difference was no longer statistically significant (HR 1.25; p=0.581). Among the OCT findings, non-culprit plaque rupture showed the strongest association with adverse outcomes (HR 3.20 for MACE; p<0.001).

OCT-Detected High-Risk Plaques Increase MACE Risk After Myocardial Infarction Despite Negative FFR

High-risk non-culprit plaques, even in the absence of significant flow limitation, are associated with an increased risk of long-term adverse clinical events after myocardial infarction. OCT identification of these plaques allows the detection of a higher-risk population that may benefit from more intensive therapeutic strategies.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...